IL36G and neoplasm: Subsequent studies in human colon cancer demonstrated the presence of IL-36γ in a variety of cell types within the tumor microenvironment, including immune cells, in particular in classically activated or M1 macrophages, tumor cells and vascular/perivascular cells (119).